The Prior Authorization Process and its Effect on Patient Care

9 years ago

By: Zachary Reale, PharmD Candidate c/o 2018 - Today there are over fifty oral anticancer agents on the market and…

Valbenazine (Ingrezza®): The First FDA Approved Drug for Tardive Dyskinesia

9 years ago

By: Yan Yi Chan, PharmD Candidate c/o 2018 - Tardive dyskinesia is a movement disorder characterized by involuntary and repetitive…

Pharmacy Lobby Day 2017, A Student’s Perspective

9 years ago

By: Zachary Reale, PharmD Candidate c/o 2018 - Every April, pharmacists and pharmacy students from all across New York State…

Lifitegrast: an alternative treatment for dry eye disease

9 years ago

By: Vicky Liu, PharmD Candidate c/o 2018 - On July 11, 2016, lifitegrast (Xiidra®), the first lymphocyte function-associated antigen 1…

Goodbye pharmacists, hello robots?

9 years ago

By: Katherine Russo, PharmD Candidate c/o 2021 - “Treat the whole patient and not the whole in the patient”  –…

Two hepatitis C drugs approved for pediatric use

9 years ago

By: Anna Diyamandoglu, PharmD Candidate c/o 2020 - Hepatitis C is an infectious disease which is caused by the hepatitis…

The function and efficacy of pimavanserin (Nuplazid®) in the treatment of psychosis associated with Parkinson’s Disease

9 years ago

By: Jonathan Mercado, PharmD Candidate c/o 2019 - In April 2016, the FDA approved the first drug specifically indicated for…

Biosimiliars: how will they affect the pharmacoeconomics of health care?

9 years ago

By: Kenny Chan, PharmD - Competition is the greatest driver of innovation and cost savings. The U.S. health care system…

A review on potassium iodide in radiological disasters

9 years ago

By: Victoria Hom, PharmD Candidate c/o 2018 - This year marked the 31st anniversary of Chernobyl, the worst nuclear disaster…

Rocket (Health) Science: Pharmaceutical Challenges at the Johnson Space Center

9 years ago

By: Kimberly Lapierre, PharmD Candidate c/o 2017 - Since its inception in 2003, the Johnson Space Center Pharmacy has taken…